KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Amortization of Deferred Charges (2016 - 2019)

Historic Amortization of Deferred Charges for Medpace Holdings (MEDP) over the last 5 years, with Q3 2019 value amounting to $80000.0.

  • Medpace Holdings' Amortization of Deferred Charges fell 4805.19% to $80000.0 in Q3 2019 from the same period last year, while for Jun 2020 it was $80000.0, marking a year-over-year decrease of 9317.41%. This contributed to the annual value of $954000.0 for FY2019, which is 5512.2% up from last year.
  • As of Q3 2019, Medpace Holdings' Amortization of Deferred Charges stood at $80000.0, which was down 4805.19% from $736000.0 recorded in Q2 2019.
  • Over the past 5 years, Medpace Holdings' Amortization of Deferred Charges peaked at $736000.0 during Q2 2019, and registered a low of $80000.0 during Q3 2019.
  • Over the past 5 years, Medpace Holdings' median Amortization of Deferred Charges value was $165500.0 (recorded in 2017), while the average stood at $342875.0.
  • Per our database at Business Quant, Medpace Holdings' Amortization of Deferred Charges plummeted by 7555.23% in 2017 and then skyrocketed by 36582.28% in 2019.
  • Quarter analysis of 5 years shows Medpace Holdings' Amortization of Deferred Charges stood at $679000.0 in 2015, then dropped by 18.7% to $552000.0 in 2016, then crashed by 70.29% to $164000.0 in 2017, then decreased by 12.2% to $144000.0 in 2018, then tumbled by 44.44% to $80000.0 in 2019.
  • Its Amortization of Deferred Charges stands at $80000.0 for Q3 2019, versus $736000.0 for Q2 2019 and $138000.0 for Q1 2019.